News and Trends 16 Jul 2024 German biotech raises $150M on its way to tackle cancer therapy resistance On its way to tackle cancer therapy resistance with its monoclonal antibody visugromab, CataLym completes a $150 million series D round. July 16, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 5 Jul 2024The radiotherapeutics boom The field of radiotherapeutics is a hot topic currently. Listen to our conversation with three experts in the field. July 5, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Inside Labiotech 3 Jul 2024 2024 survey: What can Labiotech readers tell us about the biotech industry? Explore key insights into the latest biotech industry trends based on our 2024 reader survey findings. Discover more now! July 3, 2024 - 4 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
In Depth 28 Jun 2024 Going nuclear: radiopharmaceuticals funding sees surge in 2024 Emerging as a new class of drugs, radiopharmaceuticals are all the rage in cancer treatment research as biotechs nab major funding deals. June 28, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 27 Jun 2024 The 2024 drug approval list: Eight new treatments you should know about In this article, we take a look at eight much-anticipated drugs that have been approved by regulators so far this year. June 27, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 21 Jun 2024How ADCs can deliver death cap mushroom toxins to treat cancer Listen to our conversation with Heidelberg Pharma about its lead amanitin-based ADC product candidate, HDP-101. June 21, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 13 Jun 2024 Eight companies tackling cancer with allogeneic cell therapy in 2024 Unlike autologous cell therapy, where the patient’s own cells are used, allogeneic cell therapy companies leverage donor cells, which can come from various sources such as bone marrow or umbilical cord blood. In allogeneic cell therapy, healthy donor cells are harvested, processed, and then infused into the patient. These donor cells can differentiate into various […] June 13, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 10 Jun 2024 ASCO 2024: The latest advances in oncology clinical trials Biotechs from all over the country as well as other parts of the world showcased recent pipeline advancements in oncology clinical trials at ASCO 2024. June 10, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 6 Jun 2024 Eight biotech companies advancing the field of siRNA Explore the growing sector of siRNA and discover eight biotech companies spearheading this innovative field. June 6, 2024 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 5 Jun 2024 Evolving standards of care: new treatments for cervical cancer New treatments for cervical cancer aim to broaden therapeutic options, and improve current standards of care for patients. June 5, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 30 May 2024 Covalent biologics: a new class of drugs on the horizon The field of covalent biologics has made headway recently, as the only biotech in the space has bagged $100 million to move its pipeline to the clinic. May 30, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 May 2024 Stem cell therapy’s avant-garde: Eight companies leading the way Stem cell therapy has gained traction over the recent years and the market is growing, discover eight companies advancing the field. May 30, 2024 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email